Acadian Asset Management LLC trimmed its holdings in ZimVie Inc. (NASDAQ:ZIMV – Free Report) by 45.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 380,284 shares of the company’s stock after selling 313,926 shares during the quarter. Acadian Asset Management LLC owned 1.40% of ZimVie worth $6,269,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of the business. Scarborough Advisors LLC bought a new position in ZimVie in the fourth quarter valued at about $28,000. Heritage Wealth Advisors boosted its holdings in ZimVie by 172,750.0% in the first quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock valued at $114,000 after acquiring an additional 6,910 shares during the last quarter. SG Americas Securities LLC boosted its holdings in ZimVie by 27.2% during the fourth quarter. SG Americas Securities LLC now owns 14,152 shares of the company’s stock worth $251,000 after buying an additional 3,029 shares during the last quarter. Bailard Inc. acquired a new position in shares of ZimVie during the 4th quarter worth about $254,000. Finally, Teton Advisors Inc. acquired a new position in shares of ZimVie during the 4th quarter worth about $266,000. 95.63% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC restated a “buy” rating and set a $20.00 target price on shares of ZimVie in a research report on Tuesday, June 25th.
ZimVie Stock Performance
Shares of ZimVie stock traded down $0.14 on Monday, reaching $21.68. 272,896 shares of the company were exchanged, compared to its average volume of 344,217. ZimVie Inc. has a one year low of $6.52 and a one year high of $22.40. The company has a current ratio of 2.68, a quick ratio of 2.23 and a debt-to-equity ratio of 1.32. The company has a 50-day moving average of $17.25 and a 200 day moving average of $17.29.
ZimVie (NASDAQ:ZIMV – Get Free Report) last posted its quarterly earnings results on Wednesday, May 8th. The company reported $0.08 earnings per share for the quarter. ZimVie had a positive return on equity of 2.01% and a negative net margin of 56.31%. The business had revenue of $118.20 million for the quarter. During the same quarter last year, the company posted $0.25 EPS. As a group, sell-side analysts expect that ZimVie Inc. will post 0.63 EPS for the current fiscal year.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Read More
- Five stocks we like better than ZimVie
- Buy P&G Now, Before It Sets A New All-Time High
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- Are Penny Stocks a Good Fit for Your Portfolio?
- Has This Leading Tech Stock Halted the AI Surge?
- CD Calculator: Certificate of Deposit Calculator
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV – Free Report).
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.